Literature DB >> 8349046

North-American twins with IDDM. Genetic, etiological, and clinical significance of disease concordance according to age, zygosity, and the interval after diagnosis in first twin.

D Kumar1, N S Gemayel, D Deapen, D Kapadia, P H Yamashita, M Lee, J H Dwyer, P Roy-Burman, G A Bray, T M Mack.   

Abstract

In 224 twin pairs (132 monozygotic, 86 dizygotic, and 6 of uncertain zygosity) in whom the index twin had developed IDDM before 30 yr of age, 51 of the co-twins (38 monozygotic, 10 dizygotic, and 3 of uncertain zygosity) subsequently became diabetic. On the basis of concordance ratios, which were significantly discrepant (P < 0.01) between monozygotic and dizygotic twins, the substantial genetic role in IDDM etiology is confirmed. For the monozygotic co-twin of an IDDM case, the relative risk is significantly related to an early age at proband diagnosis (P < 0.01 for 0-4 vs. 5-9 yr of age). However, among monozygotic co-twins at any age, IDDM risk decreases as time passes after the proband diagnosis (P < 0.01 for 0-23 vs. > or = 24 mo after a proband diagnosis at 5-9 yr of age). Moreover, a structural-equation analysis suggests a profound contribution to liability (as much as 79%) from the twins' shared environment. Risk to like-sex male dizygotic co-twins is as high as that to monozygotic co-twins, significantly higher than that to like-sex female dizygotic co-twins (P < 0.005), and even higher than that to male co-twins in unlike-sex dizygotic pairs (P < 0.05). Overall, the risk to the dizygotic co-twin of a case is significantly higher (P < 0.001) than that to a non-twin sibling, as reported in the literature. The observed male excess is consistent with reported patterns of IDDM in experimental animals, and in certain circumstances in humans. Taken together, these observations suggest an important early acquired determinant of IDDM, independent of genetic determinants. On the basis of Kaplan-Meier IDDM-free survival curves, if the proband is diagnosed before 15 yr of age, the long-term risk to the co-twin is estimated at 44% (monozygotic) and 19% (dizygotic); it reaches 65% for the co-twin of a monozygotic proband diagnosed before 5 yr of age. An IDDM discordant period of no more than 3 yr was observed in 60% of the pairs destined to become concordant, offering a very brief window for intervention following the recognition of high risk.

Entities:  

Mesh:

Year:  1993        PMID: 8349046     DOI: 10.2337/diab.42.9.1351

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  35 in total

1.  Autoantibodies and high-risk HLA susceptibility markers in first-degree relatives of Brazilian patients with type 1 diabetes mellitus: a progression to disease based study.

Authors:  L I Alves; E Davini; M R Correia; R T Fukui; R F Santos; M R Cunha; D M Rocha; W M G Volpini; M E R Silva
Journal:  J Clin Immunol       Date:  2012-03-09       Impact factor: 8.317

2.  Concordance odds ratios and approximate rate ratios in longitudinal twin studies.

Authors:  Moo-Song Lee; Sang-Il Lee; Seungcheol Yun; Weechang Kang
Journal:  Eur J Epidemiol       Date:  2003       Impact factor: 8.082

Review 3.  Environmental factors in the development of Type 1 diabetes.

Authors:  Hui Peng; William Hagopian
Journal:  Rev Endocr Metab Disord       Date:  2006-09       Impact factor: 6.514

Review 4.  From markers to molecular mechanisms: type 1 diabetes in the post-GWAS era.

Authors:  Alan G Baxter; Margaret A Jordan
Journal:  Rev Diabet Stud       Date:  2012-12-28

5.  Tissue- and age-specific changes in gene expression during disease induction and progression in NOD mice.

Authors:  Keiichi Kodama; Atul J Butte; Remi J Creusot; Leon Su; Deqiao Sheng; Mark Hartnett; Hideyuki Iwai; Luis R Soares; C Garrison Fathman
Journal:  Clin Immunol       Date:  2008-09-17       Impact factor: 3.969

6.  Age-dependent HLA genetic heterogeneity of IDDM in Japanese patients.

Authors:  T Awata; R Hagura; T Urakami; Y Kanazawa
Journal:  Diabetologia       Date:  1995-06       Impact factor: 10.122

Review 7.  Type 1 diabetes mellitus and multiple sclerosis: common etiological features.

Authors:  Adam E Handel; Lahiru Handunnetthi; George C Ebers; Sreeram V Ramagopalan
Journal:  Nat Rev Endocrinol       Date:  2009-11-03       Impact factor: 43.330

8.  T-cell epitopes in type 1 diabetes autoantigen tyrosine phosphatase IA-2: potential for mimicry with rotavirus and other environmental agents.

Authors:  M C Honeyman; N L Stone; L C Harrison
Journal:  Mol Med       Date:  1998-04       Impact factor: 6.354

9.  Biomarkers for type 1 diabetes.

Authors:  Sharad Purohit; Jin-Xiong She
Journal:  Int J Clin Exp Med       Date:  2008-02-29

10.  Approaches in type 1 diabetes research: A status report.

Authors:  Oindrila Raha; Subhankar Chowdhury; Samir Dasgupta; P Raychaudhuri; B N Sarkar; P Veer Raju; V R Rao
Journal:  Int J Diabetes Dev Ctries       Date:  2009-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.